A2Combination of nivolumab (nivo) + ipilimumab (ipi) in the...

Annals of Oncology 2017 / 10 Vol. 28; Iss. suppl_6

A2Combination of nivolumab (nivo) + ipilimumab (ipi) in the treatment of patients (pts) with deficient DNA mismatch repair (dMMR)/high microsatellite instability (MSI-H) metastatic colorectal cancer (mCRC): CheckMate 142 Study

Lonardi, S, Andre, T, Wong, K Y M, Morse, M, McDermott, R, Hill, A, Hendlisz, A, Lenz, H, Leach, J, Moss, R A, Cao, Z A, Ledeine, J, Kopetz, S, Overman, M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx422.001
Date:
October, 2017
File:
PDF, 78 KB
english, 2017
Conversion to is in progress
Conversion to is failed